Life style intervention improves retinopathy status-the Finnish Diabetes Prevention Study
Open accessThe DOI matches its Crossref record; 34 of the 36 references it cites were found in a registry or an index.
Abstract
The aim of the study was to find out whether participation in earlier intervention had an effect on the occurrence of retinopathy in study participants. We also examined risk factors (age, sex, weight, fasting and 2 h glucose, fasting insulin, blood pressure, serum lipids) for early retinal changes. The study included 522 individuals (mean 55 years old, range 40–64 years) with impaired glucose tolerance who were randomized into intervention (weight loss, healthy diet, and physical activity, N = 265) and control groups (N = 257). Intervention lasted for median of four years in 1993–2000, after which annual follow-up visits at study clinics were conducted. In the years 2002–2006 (at least five years after stopping intervention), fundus photography was offered for all study participants in four of five study clinics. Photographs were assessed by two experienced ophthalmologists (A.A. and K.K.), masked for the group assignment. After exclusion of poor quality photographs, the data of 211 individuals (N = 113 for intervention and N = 98 for control group) were included in the present study. The occurrence of microaneurysms was significantly higher in the control (37/98, 38%) than in the intervention group (27/113, 24%; p = 0.029). In the model, including age, sex, diabetes diagnosis before the retinal assessment, body mass index (BMI), and treatment group, the odds ratio for microaneurysms was markedly lower in intervention group (OR 0.52; 0.28–0.97, p = 0.039). The only risk factor that predicted the occurrence of microaneurysms was serum triglycerides at baseline (mean ± SD 1.9 ± 0.9 vs. 1.6 ± 0.7, mmol/L, with and without microaneurysms, respectively, p = 0.003). Triglycerides associated with decreased microaneurysms in regression analysis for age, sex, fasting glucose, and intervention group (OR 1.92, p = 0.018). Lifestyle intervention in overweight and obese individuals with impaired glucose tolerance showed decreased occurrence of retinal microaneurysms. Elevated serum triglycerides were associated to the development of early diabetic microangiopathy.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures




Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Elevated prepregnancy A1C and duration of T1D >10 years predict progression.520”
From American Association of Clinical Endocrinology Clinical Practice Guideline: Developing a Diabetes Mellitus Comprehensive Care Plan-2022 Update. (2022) · cites this paper as [520]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin
(2002) · New England Journal of Medicine · doi:10.1056/nejmoa012512 · Cited by 19,011
Tuomilehto, J., Lindström, J., Eriksson, J. G., Valle, T. T., Hämäläinen, H., Ilanne-Parikka, P., Keinänen-Kiukaanniemi, S., Laakso, M., Louheranta, A., Rastas, M., et al. (2001) · New England Journal of Medicine · doi:10.1056/nejm200105033441801 · Cited by 10,873
Self-citationIDF Diabetes Atlas: Global estimates for the prevalence of diabetes for 2015 and 2040
Ogurtsova, K., da Rocha Fernandes, J. D., Huang, Y., Linnenkamp, U., Guariguata, L., Cho, N. H., Cavan, D., Shaw, J. E., & Makaroff, L. E. (2017) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2017.03.024 · Cited by 6,966 · cited 1×
“In 2015, the global prevalence of diabetes was estimated to be 415 million [2].”
Background(2007) · Developments in Ophthalmology · doi:10.1159/isbn.978-3-318-01439-6 · Cited by 5,583
Global prevalence and major risk factors of diabetic retinopathy
Yau, J. W. Y., Rogers, S. L., Kawasaki, R., Lamoureux, E. L., Kowalski, J. W., Bek, T., Chen, S.-J., Dekker, J. M., Fletcher, A., Grauslund, J., et al. (2012) · Diabetes Care · doi:10.2337/dc11-1909 · Cited by 4,985 · cited 8×
“Globally, DR was the leading cause of blindness among the working-aged population [3,6,7].”
BackgroundInfluentialPan, X.-R., Li, G.-W., Hu, Y.-H., Wang, J.-X., Yang, W.-Y., An, Z.-X., Hu, Z.-X., Juan-Lin, Xiao, J.-Z., Cao, H.-B., et al. (1997) · Diabetes Care · doi:10.2337/diacare.20.4.537 · Cited by 4,320
IDF Diabetes Atlas: Global estimates of the prevalence of diabetes for 2011 and 2030
Whiting, D. R., Guariguata, L., Weil, C., & Shaw, J. (2011) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2011.10.029 · Cited by 3,994 · cited 1×
“Diabetes is the major metabolic disorder globally [1].”
BackgroundCheung, N., Mitchell, P., & Wong, T. Y. (2010) · The Lancet · doi:10.1016/s0140-6736(09)62124-3 · Cited by 3,288
Diabetes Prevention Program Research Group (2009) · The Lancet · doi:10.1016/s0140-6736(09)61457-4 · Cited by 3,020
Cited by
Blonde, L., Umpierrez, G. E., Reddy, S. S., McGill, J. B., Berga, S. L., Bush, M., Chandrasekaran, S., DeFronzo, R. A., Einhorn, D., Galindo, R. J., et al. (2022) · Endocrine Practice · doi:10.1016/j.eprac.2022.08.002 · Cited by 507
Prevention of Type 2 Diabetes by Lifestyle Changes: A Systematic Review and Meta-Analysis
Uusitupa, M., Khan, T. A., Viguiliouk, E., Kahleova, H., Rivellese, A. A., Hermansen, K., Pfeiffer, A., Thanopoulou, A., Salas-Salvadó, J., Schwab, U., et al. (2019) · Nutrients · doi:10.3390/nu11112611 · Cited by 465
“, 2019 [57] NS between the original intervention and control groups NS between the original intervention and control groups Less early retinopathic changes in intervention (24% vs.”
BackgroundResultSelf-citationKropp, M., Golubnitschaja, O., Mazurakova, A., Koklesova, L., Sargheini, N., Vo, T.-T. K. S., de Clerck, E., Polivka, J., Potuznik, P., Polivka, J., et al. (2023) · EPMA Journal · doi:10.1007/s13167-023-00314-8 · Cited by 468
Evidence-based European recommendations for the dietary management of diabetes
The Diabetes and Nutrition Study Group (DNSG) of the European Association for the Study of Diabetes (EASD), Aas, A.-M., Axelsen, M., Churuangsuk, C., Hermansen, K., Kendall, C. W. C., Kahleova, H., Khan, T., Lean, M. E. J., Mann, J. I., et al. (2023) · Diabetologia · doi:10.1007/s00125-023-05894-8 · Cited by 262
“…complications (restricted to women and those that did not develop diabetes) at 15 years of follow up [13], and the Finnish Diabetes Prevention Study, with reduced type 2 diabetes at 13 years and reduced early retinopathy in a subgroup analysis up to 10 years after the intervention [12, 17].”
Blood pressure control for diabetic retinopathy
Diana, V., Han, G., Abariga, S. A., Sleilati, G. G., Vedula, S. S., & Hawkins, B. S. (2023) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd006127.pub3 · Cited by 98
Kulkarni, A. A., Thool, A. R., & Daigavane, S. V. (2024) · Cureus · doi:10.7759/cureus.56674 · Cited by 117
“By effectively collaborating, multidisciplinary teams mitigate medical errors, enhance patient safety, improve outcomes, shorten hospital stays, and decrease unplanned hospital readmissions [75-77].”
BackgroundAn, X., Zhang, Y., Sun, W., Kang, X., Ji, H., Sun, Y., Jiang, L., Zhao, X., Gao, Q., Lian, F., et al. (2024) · Frontiers in Endocrinology · doi:10.3389/fendo.2024.1294819 · Cited by 56
Type 2 Diabetes Prevention Programs—From Proof-of-Concept Trials to National Intervention and Beyond
Tuomilehto, J. O., Uusitupa, M. I. J., Gregg, E. W., & Lindström, J. (2023) · Journal of Clinical Medicine · doi:10.3390/jcm12051876 · Cited by 46
“, microaneurysms, was significantly lower in the intervention than in the control group [26].”
BackgroundSelf-citationRintamäki, R. M., Rautio, N., Peltonen, M., Jokelainen, J. J., Keinanen-Kiukaanniemi, S. M., Oksa, H. H., Saaristo, T., Puolijoki, H., Saltevo, J. T., Tuomilehto, J. O., et al. (2021) · Primary care diabetes · doi:10.1016/j.pcd.2021.03.002 · Cited by 41
Self-citationThe Final Frontier in Diabetes Care: Implementing Research in Real-World Practice
Green, J. B., Crowley, M. J., Sathish, T., Maruthur, N. M., & Oldenburg, B. F. (2024) · Diabetes Care · doi:10.2337/dci24-0001 · Cited by 32
Do Nutrients and Nutraceuticals Play a Role in Diabetic Retinopathy? A Systematic Review
Milluzzo, A., Barchitta, M., Maugeri, A., Lio, R. M. S., Favara, G., Mazzone, M. G., Sciacca, L., & Agodi, A. (2022) · Nutrients · doi:10.3390/nu14204430 · Cited by 23
“Among modifiable risk factors, unhealthy lifestyles, such as dietary intake, physical activity, tobacco consumption could influence the course of DR [21,22].”
BackgroundPhysical Activity Status and Diabetic Retinopathy: A Review
AlQabandi, Y., Nandula, S. A., Boddepalli, C. S., Gutlapalli, S. D., Lavu, V. K., Abdelwahab, R. A. M., Huang, R., Potla, S., Bhalla, S., & Hamid, P. (2022) · Cureus · doi:10.7759/cureus.28238 · Cited by 25
Matuszewski, W., Baranowska-Jurkun, A., Stefanowicz-Rutkowska, M. M., Gontarz-Nowak, K., Gątarska, E., & Bandurska-Stankiewicz, E. M. (2021) · Journal of Clinical Medicine · doi:10.3390/jcm10040705 · Cited by 23
Washirasaksiri, C., Srivanichakorn, W., Borrisut, N., Sitasuwan, T., Tinmanee, R., Kositamongkol, C., Ariyakunaphan, P., Auesomwang, C., Sayabovorn, N., Chaisathaphol, T., et al. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.950225 · Cited by 17
“(Aro et al., 2019; Gong et al., 2019) A metaanalysis demonstrated that high-risk individuals with prediabetes—particularly those with atherosclerotic cardiovascular diseases—have significantly higher long-term risks of composite cardiovascular disease and total death than individuals with normal…”
BackgroundComplementary Approaches to Retinal Health Focusing on Diabetic Retinopathy
Rák, T., Kovács-Valasek, A., Pöstyéni, E., Csutak, A., & Gabriel, R. (2023) · Cells · doi:10.3390/cells12232699 · Cited by 13
“Aro et al. assessed if there was an early incorporation of lifestyle changes in diabetes therapy at the onset; this beneficially influenced the occurrence of DR [99].”
Backgroundde Mello, V. D., Selander, T. A., Lindström, J., Tuomilehto, J. O., Uusitupa, M. I. J., & Kaarniranta, K. (2021) · Nutrients · doi:10.3390/nu13124452 · Cited by 16
“In this same study, we reported that elevated serum triglycerides were associated with the development of early diabetic microangiopathy in the Finnish Diabetes Prevention Study (DPS) [11].”
BackgroundMethodSelf-citationIntraocular Pressure Fluctuation during Aerobic Exercise at Different Exercise Intensities
Kawae, T., Nomura, T., Iwaki, D., Nakashima, Y., Fudeyasu, K., Kataoka, H., Ishiguro, T., & Kimura, H. (2022) · Healthcare · doi:10.3390/healthcare10071196 · Cited by 13
“On the contrary, exercise has been reported to improve the severity of symptoms in patients with diabetic nephropathy and neuropathy, but there have been no studies on its effect in patients with retinopathy [10,11].”
BackgroundEurasian clinical practice guidelines for dietary management of cardiovascular diseases (2024)
Starodubova, A. V., Chazova, I. E., Tutelyan, V. A., Nikityuk, D. B., Pavlovskaya, E. V., Кislyak, O. A., Blinova, N. V., Brumberg, A. A. B., Bubnova, M. G., Varaeva, Y. R., et al. (2024) · Eurasian heart journal · doi:10.38109/2225-1685-2024-4-6-66 · Cited by 13
Perez, A. M., Neag, E. J., Sridhar, J. S., & Williams, B. K. (2024) · Current Opinion in Ophthalmology · doi:10.1097/icu.0000000000001038 · Cited by 11
Tumminia, A., Milluzzo, A., Carrubba, N., Vinciguerra, F., Baratta, R., & Frittitta, L. (2023) · Nutrition Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2023.10.031 · Cited by 9
Kaarniranta, K., Valtanen, M., Keinanen-Kiukaanniemi, S. M., Tuomilehto, J. O., Lindström, J., & Uusitupa, M. I. J. (2024) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgae287 · Cited by 12
Self-citationZhou, R., Cui, Y., Zhang, Y., Jin, D., An, X., Duan, Y., Zhang, Y., Kang, X., & Lian, F. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.838224 · Cited by 8
“Nanditha, 2018 (24) L L H L L L Lindström, 2006 (25) L L H L L L Aro, 2019 (14) L L H L L L”
BackgroundRozga, M., Jones, K., Robinson, J., & Yahiro, A. M. (2021) · Public Health Nutrition · doi:10.1017/s1368980021002184 · Cited by 9
“Nutrition and physical activity counseling or coaching was provided by a dietitian/nutritionist only in fifteen studies(15,32,46,47,52,83,89,101,128,139,147,151,160,162,182), an exercise practitioner only in two studies(56,184) and both a dietitian/ nutritionist and exercise practitioner in twenty-one studies(51,69,78…”
MethodMilluzzo, A., Barchitta, M., Maugeri, A., AGODI, A., & Sciacca, L. (2022) · Minerva Endocrinology · doi:10.23736/s2724-6507.22.03653-3 · Cited by 9
Kumar, G., Velu, S., Pardhan, S., Sapkota, R., Ruamviboonsuk, P., Tadarati, M., Chotcomwongse, P., Nganthavee, V., Pattanapongpaiboon, W., & Raman, R. (2023) · PLoS ONE · doi:10.1371/journal.pone.0289618 · Cited by 7
Shrateh, O. N., Abdelhafez, M., Ereqat, S., Dein, L. N. E., & Iriqat, S. (2024) · Endocrinology Diabetes & Metabolism · doi:10.1002/edm2.494 · Cited by 6
“Their findings indicated a positive impact of incorporating lifestyle changes into diabetes management plans, specifically in delaying the progression or onset of DR [42,43].”
BackgroundEstrategias para la prevención y tratamiento no farmacológico de la diabetes. Modelos de atención
López, M. A. B. (2024) · Atención Primaria · doi:10.1016/j.aprim.2024.102947 · Cited by 13
Gabriel, R., Boukichou-Abdelkader, N., Gilis‐Januszewska, A., Makrilakis, K., Gómez‐Huelgas, R., Kamenov, Z. A., Paulweber, B., Satman, İ., Djordjević, P., Alkandari, A., et al. (2023) · Journal of Clinical Medicine · doi:10.3390/jcm12052035 · Cited by 7
“Experimental studies have reported that linagliptin has a protective effect on the microvasculature of the diabetic retina, most likely due to a combination of neuroprotective and antioxidative beneficial effects [26].”
BackgroundSelf-citationAlShammari, A. Z. A. M., Alhamad, F. F., Abdelgadir, Z. E. E., AlShammari, H. M., Al-Ahmadi, M., & Alharbi, K. F. O. (2025) · Cureus · doi:10.7759/cureus.82411 · Cited by 4
Luo, C., Zheng, Z., Zeng, M.-Q., Xu, H. N., Yu, X. F., Sun, D., & He, D. (2025) · World Journal of Diabetes · doi:10.4239/wjd.v16.i6.107017 · Cited by 5
Uusitupa, M. I. J. (2019) · Annals of Translational Medicine · doi:10.21037/atm.2019.08.123 · Cited by 4
Self-citationMilluzzo, A., Maugeri, A., Barchitta, M., Lio, R. M. S., Rocca, D., Marino, A., Frittitta, L., Sciacca, L., & Agodi, A. (2026) · Nutrients · doi:10.3390/nu18121970 · Cited by 3
Weight Reduction as an Adjunctive Management Strategy for Diabetic Retinopathy.
Rajagopal, R. (2022) · PubMed · Cited by 5
Haas, J., Rogge, A., Otto, B., Michel, N., Berg, D., & Schaeffer, E. (2026) · BMC Neurology · doi:10.1186/s12883-026-04703-0 · Cited by 1
“For other lifestyle-related diseases such as diabetes, organized lifestyle interventions have been in place for years and have shown highly promising results in reducing blood sugar and improving insulin resistance as well as reducing diabetes-associated complications [17–20].”
RETINOPATI DIABETIK: PATOGENESIS, DIAGNOSIS, TATALAKSANA KINI DAN MASA DEPAN
Ulfayani, N., & Haitsam, M. (2023) · Jurnal Klinik dan Riset Kesehatan · doi:10.11594/jk-risk.03.1.4 · Cited by 3
Exercício Físico e Nutrição no Tratamento da Diabetes Mellitus tipo 2
da Silva, M. D. G. B., Primo, A. C. D. C., Silva, P. A. B., dos Santos, E. A., de Medeiros, G. R., Rubio, V. H. B., Camargo, N. D. S., da Ponte, R. V., da Silva, G. J., & Santos, D. W. T. (2024) · Brazilian Journal of Implantology and Health Sciences · doi:10.36557/2674-8169.2024v6n12p2885-2893 · Cited by 2
Khosravani, E., Sanagou, G., Shirazi, M., & Rezaei, M. (2022) · Jundishapur Journal of Chronic Disease Care · doi:10.5812/jjcdc-120697 · Cited by 1
“People with diabetes are anxious about social interactions due to constant life changes, fear of high blood sugar, and understanding how they differ from others (1).”
BackgroundIdentifying Risk Factors Associated with the Development of Diabetic Retinopathy in Local Population
Tariq, E., Waheed, P., Rashid, A., & Majeed, A. (2022) · Pakistan Armed Forces Medical Journal · doi:10.51253/pafmj.v72i6.9044
Hu, X., Liang, Y.-C., Fang, Z.-B., Huang, B.-L., Chu, S.-F., Liu, D.-L., & Li, H.-L. (2023) · Research Square · doi:10.21203/rs.3.rs-3671476/v1
Sievenpiper, J. L., & Chiavaroli, L. (2025) · American Journal of Clinical Nutrition · doi:10.1016/j.ajcnut.2024.12.020
Diabetic Retinopathy: Does 12 Weeks of Intensive Lifestyle Intervention Cause Any Improvement?
Talmale, P. M., Phatak, M. S., & Hingorani-Bang, P. (2026) · Journal of the Association of Physicians of India · doi:10.59556/japi.74.1437
Shan, H., & Cao, J. (2026) · Clinical and Experimental Optometry · doi:10.1080/08164622.2026.2652027
“30 Consequently, variations across the blood glucose control methods may play a critical role in the progression of diabetic RMA.”
Hormenu, T., Antiri, E. O., Ocansey, S., & Ansah, E. W. (2026) · Dialogues in Health · doi:10.1016/j.dialog.2026.100314
“[35 – 37], and Northern America (25”
InfluentialTambone, V. (2026) · American Diabetes Association eBooks · doi:10.2337/9781580408493-ch07
Kowluru, R. A., Kaur, I., Wang, S., Kaarniranta, K., & Malaviya, P. B. (2026) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2026.101511
Self-citationShrestha, R., Adhikari, C., Shrestha, M. K., Paneru, D. P., Dawadi, A., & Uma, D. C. (2026) · PLoS ONE · doi:10.1371/journal.pone.0357023
Metadata
- Authors
- Aro, A., Kauppinen, A., Kivinen, N., Selander, T., Kinnunen, K., Tuomilehto, J., Keinänen-Kiukaanniemi, S., Lindström, J., Uusitupa, M., & Kaarniranta, K.
- Affiliations
- North Karelia Central Hospital (FI)
- University of Eastern Finland (FI)
- Kuopio University Hospital (FI)
- Dasman Diabetes Institute (KW)
- Center for Life Course Health Research, University of Oulu, 90014 Oulu, Finland
- Finnish Institute for Health and Welfare (FI)
- Corresponding author
- Kaarniranta, K.
- Venue
- Nutrients
- Publisher
- MDPI AG
- Published
- 2019-07-23
- Volume
- 11
- Issue
- 7
- Pages
- 1691
- ISSN
- 2072-6643 (ISSN-L)
- PMC
- PMC6683279
- OpenAlex
- W2963967140
- Cited by
- 46
- References
- 36
- Citations by year
- 2026: 8 · 2025: 3 · 2024: 9 · 2023: 10 · 2022: 10 · 2021: 4 · 2019: 2
- FWCI
- 3.93
- Type
- journal article
- Language
- en
- Open access
- gold
- dx.doi.org
- Licence
- Locations
- Nutrients (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- STM:n Hallinnonalan avoin julkaisuarkisto (Julkari) (submittedVersion)
- WOS
- Topics
- Health Sciences › Medicine › Ophthalmology › Retinal Diseases and Treatments
- Health Sciences › Medicine › Radiology, Nuclear Medicine and Imaging › Retinal Imaging and Analysis
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Keywords
- diabetic retinopathy, microaneurysms, impaired glucose tolerance, type 2 diabetes prevention, serum triglycerides, diabetic microangiopathy, overweight and obesity, weight loss, physical activity, healthy eating, risk factors
- MeSH terms
- Healthy Lifestyle, Microaneurysm, Diet, Healthy, Adult, Blood Glucose, Female, Finland, Humans, Male, Middle Aged, Obesity, Retinal Diseases, Risk Factors, Time Factors, Triglycerides, Biomarkers, Weight Loss, Exercise, Treatment Outcome, Glucose Intolerance, Risk Assessment, Risk Reduction Behavior, Protective Factors
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.